Bioray Biotech Co., Ltd (TPEX:7561)
Taiwan
· Delayed Price · Currency is TWD 23.10
-0.50 (-2.12%)
Mar 10, 2026, 11:23 AM CST
Bioray Biotech Ratios and Metrics
Market cap in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2016 |
| Market Capitalization | 698 | 635 | 930 | 901 | 1,290 | 826 | Upgrade
|
| Market Cap Growth | 5.42% | -31.64% | 3.17% | -30.18% | 56.23% | - | Upgrade
|
| Enterprise Value | 595 | 586 | 911 | 896 | 1,226 | 756 | Upgrade
|
| Last Close Price | 23.60 | 21.30 | 30.90 | 29.76 | 46.51 | 29.94 | Upgrade
|
| PE Ratio | 23.01 | 634.18 | - | 1802.11 | - | - | Upgrade
|
| PS Ratio | 3.03 | 3.15 | 4.85 | 4.73 | 8.72 | 5.29 | Upgrade
|
| PB Ratio | 1.59 | 1.51 | 2.14 | 2.00 | 3.55 | 2.22 | Upgrade
|
| P/TBV Ratio | 1.59 | 1.51 | 2.15 | 2.01 | 3.58 | 2.26 | Upgrade
|
| P/FCF Ratio | 22.34 | 47.32 | - | - | - | - | Upgrade
|
| P/OCF Ratio | 20.82 | 38.16 | - | 363.62 | 146.17 | 493.43 | Upgrade
|
| EV/Sales Ratio | 2.58 | 2.90 | 4.75 | 4.70 | 8.29 | 4.84 | Upgrade
|
| EV/EBITDA Ratio | 10.10 | 48.59 | - | 56.76 | 230.50 | 80.79 | Upgrade
|
| EV/FCF Ratio | 19.02 | 43.61 | - | - | - | - | Upgrade
|
| Debt / Equity Ratio | 0.12 | 0.20 | 0.16 | 0.22 | 0.15 | 0.17 | Upgrade
|
| Debt / EBITDA Ratio | 0.87 | 4.26 | 13.55 | 4.68 | 4.99 | 4.11 | Upgrade
|
| Debt / FCF Ratio | 1.64 | 6.39 | - | - | - | - | Upgrade
|
| Net Debt / Equity Ratio | -0.23 | -0.22 | -0.06 | -0.08 | -0.20 | -0.23 | Upgrade
|
| Net Debt / EBITDA Ratio | -2.07 | -7.67 | 16.42 | -2.42 | -13.70 | -9.01 | Upgrade
|
| Net Debt / FCF Ratio | -3.31 | -6.88 | 2.53 | 0.67 | 11.85 | 1.71 | Upgrade
|
| Asset Turnover | 0.43 | 0.37 | 0.34 | 0.36 | 0.31 | 0.32 | Upgrade
|
| Inventory Turnover | 2.17 | 2.40 | 2.10 | 2.24 | 1.72 | 2.10 | Upgrade
|
| Quick Ratio | 5.30 | 5.33 | 3.52 | 2.77 | 2.20 | 2.33 | Upgrade
|
| Current Ratio | 7.15 | 6.98 | 5.00 | 3.69 | 2.83 | 3.02 | Upgrade
|
| Return on Equity (ROE) | 7.12% | 0.23% | -2.61% | 0.12% | -2.16% | -0.38% | Upgrade
|
| Return on Assets (ROA) | 4.13% | -0.50% | -2.12% | -0.04% | -1.08% | -0.03% | Upgrade
|
| Return on Invested Capital (ROIC) | 8.42% | -0.85% | -4.71% | -0.07% | -2.80% | -0.08% | Upgrade
|
| Return on Capital Employed (ROCE) | 7.40% | -0.90% | -3.90% | -0.10% | -2.10% | -0.10% | Upgrade
|
| Earnings Yield | 4.37% | 0.16% | -1.24% | 0.06% | -0.56% | -0.01% | Upgrade
|
| FCF Yield | 4.48% | 2.11% | -1.16% | -6.34% | -0.48% | -5.97% | Upgrade
|
| Dividend Yield | - | - | - | 0.67% | - | - | Upgrade
|
| Buyback Yield / Dilution | 1.61% | 0.83% | -7.37% | -4.67% | -0.14% | 0.09% | Upgrade
|
| Total Shareholder Return | 1.61% | 0.83% | -7.37% | -3.99% | -0.14% | 0.09% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.